CalciMedica, Inc. (CALC)

CalciMedica Statistics

Total Valuation

CalciMedica has a market cap or net worth of $9.72 million. The enterprise value is $8.26 million.

Market Cap	9.72M
Enterprise Value	8.26M

Important Dates

The last earnings date was Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

CalciMedica has 15.74 million shares outstanding. The number of shares has increased by 25.12% in one year.

Current Share Class	15.74M
Shares Outstanding	15.74M
Shares Change (YoY)	+25.12%
Shares Change (QoQ)	+3.08%
Owned by Insiders (%)	16.76%
Owned by Institutions (%)	17.32%
Float	9.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.61

Current Ratio	1.61
Quick Ratio	1.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.18

Financial Efficiency

Return on equity (ROE) is -399.51% and return on invested capital (ROIC) is -110.80%.

Return on Equity (ROE)	-399.51%
Return on Assets (ROA)	-81.85%
Return on Invested Capital (ROIC)	-110.80%
Return on Capital Employed (ROCE)	-674.61%
Weighted Average Cost of Capital (WACC)	12.32%
Revenue Per Employee	n/a
Profits Per Employee	-$1.22M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.13% in the last 52 weeks. The beta is 1.10, so CalciMedica's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	-69.13%
50-Day Moving Average	0.64
200-Day Moving Average	2.58
Relative Strength Index (RSI)	46.91
Average Volume (20 Days)	128,306

Short Selling Information

The latest short interest is 167,953, so 1.07% of the outstanding shares have been sold short.

Short Interest	167,953
Short Previous Month	372,157
Short % of Shares Out	1.07%
Short % of Float	1.84%
Short Ratio (days to cover)	0.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.24M
Pretax Income	-19.54M
Net Income	-19.54M
EBITDA	-22.19M
EBIT	-22.24M
Earnings Per Share (EPS)	-$1.27

Balance Sheet

The company has $8.16 million in cash and $6.70 million in debt, with a net cash position of $1.46 million or $0.09 per share.

Cash & Cash Equivalents	8.16M
Total Debt	6.70M
Net Cash	1.46M
Net Cash Per Share	$0.09
Equity (Book Value)	-1.10M
Book Value Per Share	-0.07
Working Capital	3.24M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	42,500
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CalciMedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.12%
Shareholder Yield	-25.12%
Earnings Yield	-201.06%
FCF Yield	n/a

Analyst Forecast

The average price target for CalciMedica is $10.33, which is 1,573.15% higher than the current price. The consensus rating is "Buy".

Price Target	$10.33
Price Target Difference	1,573.15%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1